Genexine, Inc.
39
1
2
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.3%
4 terminated/withdrawn out of 39 trials
85.7%
-0.8% vs industry average
3%
1 trials in Phase 3/4
4%
1 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (39)
Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
Role: collaborator
Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer
Role: lead
Clinical Trial of Efepoetin Alfa in Healthy Subjects
Role: lead
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults
Role: lead
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
Role: lead
The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer
Role: lead
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Role: lead
Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)
Role: lead
Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals
Role: lead
GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
Role: lead
Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19
Role: lead
Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines
Role: lead
Individual Patient Compassionate Use of GX-I7
Role: lead
Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
Role: lead
Safety and Tolerability of GX-P1 in Healthy Male Volunteers
Role: lead
A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19
Role: collaborator
Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
Role: lead
Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients
Role: lead
GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors
Role: lead
Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors
Role: lead